Rifaximin (XIFAXAN) for the prevention of hepatic encephalopathy

Switching of levothyroxine preparations

Mistletoe for cancer: What is the current state of scientific knowledge?

Rebates according to the Pharmaceutical Market Restructuring Act in Germany (AMNOG) in relation to comparative treatment and added benefit

Switching to generics in antiepileptic treatment

Sanofi - fines for disinformation campaign against clopidogrel generics

Physical therapy first option for knee osteoarthritis with meniscal tear

TEBONIN 120 mg BEI OHRGERÄUSCHEN [Ginkgo biloba for tinnitus]

FUMADERM, progressive multifocal leukoencephalopathy and the Federal Institute for Drugs and Medical Devices (BfArM)

Counterfeit medicines - a growing problem

Lichenoid reactions on beta-receptor blockers

Minocycline (SKID u.a.): market withdrawal overdue

© arznei-telegramm 6/2013